News

Net Product Sales Increased 77% Year-over-Year to $3.1 Million Sustained Momentum Driven by Growing Prescriber Adoption and ...
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the "Company" or ...
Investors have been on edge as tariff threats, geopolitical tensions, and recession fears create a volatile trading ...
U.S. stocks are holding relatively steady following a report that showed inflation unexpectedly slowed across the country ...
Shares have logged modest gains in most world markets as the initial euphoria over the 90-day truce in the trade war between ...